... if really reverse .. and uptrend ... the upside will be at least 20-30% Short term .. before another correction ... probably can position to jump in the North train ... :P
.. looking back the Chart ... since October .. each month at least have 1 cycle uptrend and correction ... and each correction was closed and reversed higher from previous one > higher low .... looks like is a long term uptrend ... difficult to expect suddenly 1 month reach 1.00 like other vaccine Play counters .. :D ...
... unless like William said .... Bioalpha need the "Blessing" from both Malaysia and China Government to get the Vaccine Biz approval ... just HOPE. Need more blessing ... haha
.. really HOPE the approval has been granted la ... Msia Government (PNB and MTDC) invested 20+% shares in Bioalpha ... William said both big boy already sounded to him that they need to receive Dividend in 2021FY ... and transfer to Main Board by 2022 ... both whippped William to deliver HUGE profit in 2021 ... Bioalpha really need some Government blessing :D
Yes, many things cannot be revealed one by one. William has been out to publicize the company. Maybe no one is watching now. When the stock price rises again, many people will watch the boss’s live broadcast. What we have to do is to see the future before others Trend, when everyone comes in, it may be time for you to come out with a smile.
Bioalpha board members { 4 of them are nominated by government} out of the 8 key management team { excluding the 2 co secretaries} by GOM and Mtdc} operation under William the rest control by the board
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
LOL i onlywant why you sold, i dunno why people here all so panic want have quick return. Want quick return go speculation stock like vivocom la, dont come here. this one long term steady growth stock. I will buy in every month on a fix date on bio for 3 years. been collecting since end of 2018. bio is a steady growth company.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Batam
348 posts
Posted by Batam > 2020-12-09 12:05 | Report Abuse
Time to averaging down